Skip to main content
Contact Us
Subscribe
E-Edition
75°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dexcom Inc
(NQ:
DXCM
)
70.43
-1.49 (-2.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Dexcom Inc
< Previous
1
2
3
4
5
6
7
Next >
Diversified Abbott Laboratories Could Reverse And Move Higher
April 19, 2023
Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline.
Via
MarketBeat
Exposures
COVID-19
Healthcare Innovation Drives Medical Device Makers To New Highs
April 17, 2023
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base.
Via
MarketBeat
Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin
April 17, 2023
From
Dexcom, Inc.
Via
Business Wire
Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time
April 06, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Publishes Annual Sustainability Report
April 05, 2023
From
DexCom, Inc.
Via
Business Wire
DexCom Comments on SVB Relationship
March 13, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Announces Upcoming Conference Presentations
February 23, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch
February 13, 2023
From
Dexcom, Inc.
Via
Business Wire
Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
February 09, 2023
From
DexCom, Inc.
Via
Business Wire
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expanding Platform to Integrate Market-Leading CGM Data
February 08, 2023
Via
Investor Brand Network
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System
February 07, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time
January 24, 2023
From
DexCom, Inc.
Via
Business Wire
Insulet Has Potential To Gain More Than Analysts Are Forecasting
January 18, 2023
Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range.
Via
MarketBeat
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
January 09, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Appoints Teri Lawver as Chief Commercial Officer
January 09, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
DexCom, Inc.
Via
Business Wire
Can FDA Approval Bolster DexCom, Inc.?
December 14, 2022
Dexcom is relying on the interest and sales of its new continuous glucose monitor--which recently received FDA approval--to boost revenue (and stock value).
Via
MarketBeat
Exposures
Product Safety
Kaival Brands ($KAVL) and KMS gear up for anticipated revenue growth by hiring former Swisher International VP of Sales
December 12, 2022
Via
AB Newswire
Topics
Economy
Exposures
Interest Rates
Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.
December 08, 2022
From
DexCom, Inc.
Via
Business Wire
Dexcom Announces Upcoming Conference Presentation
November 22, 2022
From
DexCom, Inc.
Via
Business Wire
S&P 500 Component DexCom Set For Further Price, Earnings Growth
November 13, 2022
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
CapitalGainsReport Sector Spotlight: Wearable Health (DXCM, WHSI, IRTC, BTCY)
November 07, 2022
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care
November 01, 2022
From
DexCom, Inc.
Via
Business Wire
Dexcom Reports Third Quarter 2022 Financial Results
October 27, 2022
From
DexCom, Inc.
Via
Business Wire
Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes
October 24, 2022
From
DexCom, Inc.
Via
Business Wire
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
October 04, 2022
From
DexCom, Inc.
Via
Business Wire
Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time.
September 29, 2022
From
DexCom, Inc.
Via
Business Wire
Dexcom Announces Upcoming Conference Presentations
September 01, 2022
From
DexCom, Inc.
Via
Business Wire
DexCom Promotes Jake Leach to Chief Operating Officer
August 31, 2022
From
DexCom, Inc.
Via
Business Wire
Dexcom Announces Upcoming Conference Presentation
August 03, 2022
From
DexCom, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.